MEDEXUS PHARMACEUTIC.
Research MEDEXUS PHARMACEUTIC. (P731) on Bullrun: market cap EUR 96.79M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerP731
- ExchangeF
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 96.79M
- Financial periodQ1 2026
- RevenueUSD 24.65M
- Net income-USD 2.68M
- Free cash flow-USD 11.22M
- Gross margin53.8%
Valuation Snapshot
latest market cap is EUR 96.79M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 108.33M | USD 2.25M | USD 21.31M | 52.2% | 0.08 | USD 23.97M | USD 37.18M | USD 52.14M |
| FY2024 | USD 113.05M | -USD 214.00K | USD 18.45M | 52.6% | -0.01 | USD 5.26M | USD 49.90M | USD 30.32M |
| FY2023 | USD 108.10M | USD 1.22M | -USD 1.81M | 55.5% | 0.06 | USD 13.07M | USD 70.08M | USD 22.45M |
| FY2022 | USD 76.70M | -USD 2.88M | -USD 8.89M | 49.4% | -0.15 | USD 10.02M | USD 54.86M | USD 17.79M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-15 | EUR 96.79M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About MEDEXUS PHARMACEUTIC.
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its primary products include IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis, psoriasis, and juvenile idiopathic arthritis;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is MEDEXUS PHARMACEUTIC.'s market cap?
MEDEXUS PHARMACEUTIC.'s market capitalization is EUR 96.79M.
What does MEDEXUS PHARMACEUTIC. do?
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases.